Amgen Prices $4 Billion Senior Unsecured Notes Offering

Amgen successfully raised approximately $3.96 billion through a multi-tranche senior unsecured notes offering on February 17, 2026. The notes, maturing between 2031 and 2056 with varying coupons, include investor protections such as a change-of-control provision. Amgen stock is currently rated as a Hold by analysts with a $375 price target, while TipRanks’ AI Analyst, Spark, rates it as Outperform, citing strong technical strength and supportive earnings outlook despite financial risks from leverage.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)